DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Postpartum Family Planning Service Through Enhanced Family Planning in Immunization Services

Information source: FHI 360
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Contraception

Intervention: Family planning for postpartum women (Behavioral)

Phase: N/A

Status: Completed

Sponsored by: FHI 360

Official(s) and/or principal investigator(s):
Lisa S Dulli, PhD, MHS, Principal Investigator, Affiliation: FHI 360
Steve Sortijas, MPH, Study Director, Affiliation: FHI 360
Fidèle Ngabo, MD, MPH, Principal Investigator, Affiliation: Rwanda Ministry of Health

Summary

The purpose of this study is to determine the effectiveness of an intervention, which is designed to increase contraceptive prevalence among postpartum women attending vaccination services who desire to either space or limit their pregnancies, thus reducing unmet contraceptive need in this population.

Clinical Details

Official title: Improving Access to and Uptake of Postpartum Family Planning Service Through Enhanced Family Planning in Immunization Services

Study design: Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research

Primary outcome: Use of a modern contraceptive method among postpartum women

Detailed description: Study Goal: To determine the effectiveness of an intervention, which is designed to increase contraceptive prevalence among postpartum women attending vaccination services who desire to either space or limit their pregnancies, thus reducing unmet contraceptive need in this population. The Intervention: A. Brief, concise messages conveyed to women during group education sessions regarding pregnancy risk, benefits of FP, and family planning options during the postpartum period. B. IEC materials such as posters and brochures that deliver messages about the benefits of spacing pregnancies by at least 2 years, LAM, return to fecundity and pregnancy risk during the postpartum period and contraceptive options for postpartum women. C. Use of a screening tool (Appendix A) to assess pregnancy risk for postpartum women coupled with a brief counseling message depending upon risk classification which includes referral to FP services for those currently or soon-to-be at-risk of pregnancy. D. Convenient offer of FP services to women attending vaccination services for their infants either concurrently with vaccination services, or at the same facility and on the same day, but at a different time from vaccination services. Study Design: Experimental, two-group (intervention/control) pretest (pre-intervention) /posttest (post-intervention) design 12 month intervention period. A mid-course collection of process data will also be conducted at 6 months to assess the degree to which the intervention is being implemented as intended and to provide an opportunity for corrective action if needed. Participants: Women attending vaccination services for their infants, and vaccination and FP providers

Eligibility

Minimum age: 18 Years. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion Criteria: Clients:

- adult women, aged 21 years and older, or married women ages 18 to 20 who have

achieved legal majority status by emancipation due to marriage,

- bring their infants between the ages 6-12 months to immunization services at study

sites Providers:

- all health care providers who currently provide immunization services to infants

and/or family planning services within the selected facilities.

Locations and Contacts

Rwanda health care facilities, Kigali, Rwanda
Additional Information

Starting date: February 2010
Last updated: March 28, 2012

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017